Dietary Advanced Glycation End Products and Their Potential Role in Cardiometabolic Disease in Children

20164,017 citationsReviewbronze Open Access

Authors

Anshu Gupta · Virginia Commonwealth University

Jaime Uribarri · Icahn School of Medicine at Mount Sinai

Abstract

Intensive blood-glucose control by either sulphonylureas or insulin substantially decreases the risk of microvascular complications, but not macrovascular disease, in patients with type 2 diabetes.(ABSTRACT TRUNCATED)

Topics & Keywords

Advanced Glycation End Products research Natural Antidiabetic Agents Studies Diabetes, Cardiovascular Risks, and Lipoproteins

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Hormone Research in Paediatrics

Volume 85, Issue 5, pp. 291-300

DOI: 10.1159/000444053

Field-Weighted Citation Impact: 289.13